Training medical students in genomic medicine
Official title: Genomic Medicine Master's Degree Program for Medical Students
Funded at University of California, San Francisco · NIH-10768286 · Data updated 2026-11-12
This study is creating a one-year Master's program in Genomic Medicine for medical students at UCSF to help them learn how to use genetics in diagnosing and treating diseases, making sure they are well-prepared for the future of healthcare.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 18, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $485,847 |
| NIH project number | 1R25HG012725-01A1 |
| Project ID | NIH-10768286 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this program are medical students at UCSF who have completed their clinical clerkships and are interested in expanding their knowledge of genetics.
✕Less likely to help
Patients who are not involved in the medical education process or who do not have access to UCSF may not benefit directly from this research.
What this research studies
This research aims to develop a one-year Master of Science program in Genomic Medicine for medical students at UCSF. It addresses the growing need for clinicians who are well-versed in genetics and genomics, particularly as these fields become increasingly important in diagnosing and treating diseases. The program will incorporate active learning strategies and focus on practical applications of genetic knowledge, ensuring that future physicians are equipped to use genetic information effectively in their practice. Students will engage in courses that cover various aspects of genetics, including testing, interpretation, and ethical considerations.
Why it matters
Potential benefit: If successful, this program could significantly enhance the ability of future physicians to integrate genomic medicine into patient care.
How similar studies have gone: Similar educational initiatives in genomic medicine have shown promise in enhancing clinician competence, indicating a positive outlook for this program.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Risch, Neil J. — University of California, San Francisco
- Study coordinator: Risch, Neil J.
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.